{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T14:10:34Z","timestamp":1774879834458,"version":"3.50.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,11,19]],"date-time":"2010-11-19T00:00:00Z","timestamp":1290124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurosci"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1038\/nrn2935","type":"journal-article","created":{"date-parts":[[2010,11,19]],"date-time":"2010-11-19T10:48:05Z","timestamp":1290163685000},"page":"791-797","source":"Crossref","is-referenced-by-count":476,"title":["The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Mark R.","family":"Cookson","sequence":"first","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,11,19]]},"reference":[{"key":"BFnrn2935_CR1","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","volume":"373","author":"AJ Lees","year":"2009","unstructured":"Lees, A. J., Hardy, J. & Revesz, T. Parkinson's disease. Lancet 373, 2055\u20132066 (2009).","journal-title":"Lancet"},{"key":"BFnrn2935_CR2","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1017\/S1462399409001148","volume":"11","author":"T Gasser","year":"2009","unstructured":"Gasser, T. Molecular pathogenesis of Parkinson disease: insights from genetic studies. Expert Rev. Mol. Med. 11, e22 (2009).","journal-title":"Expert Rev. Mol. Med."},{"key":"BFnrn2935_CR3","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/ng.485","volume":"41","author":"W Satake","year":"2009","unstructured":"Satake, W. et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nature Genet. 41, 1303\u20131307 (2009).","journal-title":"Nature Genet."},{"key":"BFnrn2935_CR4","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/ng.487","volume":"41","author":"J Simon-Sanchez","year":"2009","unstructured":"Simon-Sanchez, J. et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nature Genet. 41, 1308\u20131312 (2009).","journal-title":"Nature Genet."},{"key":"BFnrn2935_CR5","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","volume":"44","author":"C Paisan-Ruiz","year":"2004","unstructured":"Paisan-Ruiz, C. et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44, 595\u2013600 (2004).","journal-title":"Neuron"},{"key":"BFnrn2935_CR6","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich, A. et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601\u2013607 (2004).","journal-title":"Neuron"},{"key":"BFnrn2935_CR7","doi-asserted-by":"publisher","first-page":"16906","DOI":"10.1074\/jbc.M708718200","volume":"283","author":"E Greggio","year":"2008","unstructured":"Greggio, E. et al. The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation. J. Biol. Chem. 283, 16906\u201316914 (2008).","journal-title":"J. Biol. Chem."},{"key":"BFnrn2935_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.bbrc.2009.08.163","volume":"389","author":"E Greggio","year":"2009","unstructured":"Greggio, E. et al. The Parkinson's disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites. Biochem. Biophys. Res. Commun. 389, 449\u2013454 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrn2935_CR9","doi-asserted-by":"publisher","first-page":"10963","DOI":"10.1021\/bi9011379","volume":"48","author":"S Kamikawaji","year":"2009","unstructured":"Kamikawaji, S., Ito, G. & Iwatsubo, T. Identification of the autophosphorylation sites of LRRK2. Biochemistry 48, 10963\u201310975 (2009).","journal-title":"Biochemistry"},{"key":"BFnrn2935_CR10","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1471-4159.2009.06358.x","volume":"111","author":"CL Klein","year":"2009","unstructured":"Klein, C. L. et al. Homo- and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment. J. Neurochem. 111, 703\u2013715 (2009).","journal-title":"J. Neurochem."},{"key":"BFnrn2935_CR11","doi-asserted-by":"publisher","first-page":"5511","DOI":"10.1021\/bi100157u","volume":"49","author":"Z Berger","year":"2010","unstructured":"Berger, Z., Smith, K. A. & Lavoie, M. J. Membrane localization of LRRK2 is associated with increased formation of the highly active LRRK2 dimer and changes in its phosphorylation. Biochemistry 49, 5511\u20135523 (2010).","journal-title":"Biochemistry"},{"key":"BFnrn2935_CR12","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1021\/pr9008578","volume":"9","author":"CJ Gloeckner","year":"2010","unstructured":"Gloeckner, C. J. et al. Phosphopeptide analysis reveals two discrete clusters of phosphorylation in the N-terminus and the Roc domain of the Parkinson-disease associated protein kinase LRRK2. J. Proteome Res. 9, 1738\u20131745 (2010).","journal-title":"J. Proteome Res."},{"key":"BFnrn2935_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1042\/BJ20100784","volume":"430","author":"N Dzamko","year":"2010","unstructured":"Dzamko, N. et al. Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)\/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localization. Biochem. J. 430, 405\u2013413 (2010).","journal-title":"Biochem. J."},{"key":"BFnrn2935_CR14","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nature09191","volume":"466","author":"S Gehrke","year":"2010","unstructured":"Gehrke, S., Imai, Y., Sokol, N. & Lu, B. Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature 466, 637\u2013641 (2010).","journal-title":"Nature"},{"key":"BFnrn2935_CR15","first-page":"1826","volume":"12","author":"Y Li","year":"2009","unstructured":"Li, Y. et al. Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nature Neurosci. 12, 1826\u20131828 (2009).","journal-title":"Nature Neurosci."},{"key":"BFnrn2935_CR16","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.neuron.2009.11.006","volume":"64","author":"X Lin","year":"2009","unstructured":"Lin, X. et al. Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant \u03b1-synuclein. Neuron 64, 807\u2013827 (2009).","journal-title":"Neuron"},{"key":"BFnrn2935_CR17","doi-asserted-by":"publisher","first-page":"9879","DOI":"10.1073\/pnas.1004676107","volume":"107","author":"Y Tong","year":"2010","unstructured":"Tong, Y. et al. Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of \u03b1-synuclein, and apoptotic cell death in aged mice. Proc. Natl Acad. Sci. USA 107, 9879\u20139884 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrn2935_CR18","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/nm.2199","volume":"16","author":"BD Lee","year":"2010","unstructured":"Lee, B. D. et al. Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease. Nature Med. 16, 998\u20131000 (2010).","journal-title":"Nature Med."},{"key":"BFnrn2935_CR19","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1523\/JNEUROSCI.5604-09.2010","volume":"30","author":"X Li","year":"2010","unstructured":"Li, X. et al. Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S. J. Neurosci. 30, 1788\u20131797 (2010).","journal-title":"J. Neurosci."},{"key":"BFnrn2935_CR20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.nbd.2010.07.010","volume":"40","author":"HL Melrose","year":"2010","unstructured":"Melrose, H. L. et al. Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice. Neurobiol. Dis. 40, 503\u2013517 (2010).","journal-title":"Neurobiol. Dis."},{"key":"BFnrn2935_CR21","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/ana.20808","volume":"59","author":"D Galter","year":"2006","unstructured":"Galter, D. et al. LRRK2 expression linked to dopamine-innervated areas. Ann. Neurol. 59, 714\u2013719 (2006).","journal-title":"Ann. Neurol."},{"key":"BFnrn2935_CR22","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1016\/j.yexcr.2007.07.007","volume":"313","author":"L Guo","year":"2007","unstructured":"Guo, L. et al. The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity. Exp. Cell Res. 313, 3658\u20133670 (2007).","journal-title":"Exp. Cell Res."},{"key":"BFnrn2935_CR23","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/j.bbrc.2007.04.006","volume":"357","author":"PA Lewis","year":"2007","unstructured":"Lewis, P. A. et al. The R1441C mutation of LRRK2 disrupts GTP hydrolysis. Biochem. Biophys. Res. Commun. 357, 1668\u20131671 (2007).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrn2935_CR24","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.nbd.2006.04.001","volume":"23","author":"E Greggio","year":"2006","unstructured":"Greggio, E. et al. Kinase activity is required for the toxic effects of mutant LRRK2\/dardarin. Neurobiol. Dis. 23, 329\u2013341 (2006).","journal-title":"Neurobiol. Dis."},{"key":"BFnrn2935_CR25","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1042\/BJ20070209","volume":"405","author":"M Jaleel","year":"2007","unstructured":"Jaleel, M. et al. LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity. Biochem. J. 405, 307\u2013317 (2007).","journal-title":"Biochem. J."},{"key":"BFnrn2935_CR26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1042\/BJ20100483","volume":"430","author":"RJ Nichols","year":"2010","unstructured":"Nichols, R. J. et al. 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization. Biochem. J. 430, 393\u2013404 (2010).","journal-title":"Biochem. J."},{"key":"BFnrn2935_CR27","doi-asserted-by":"publisher","first-page":"16842","DOI":"10.1073\/pnas.0507360102","volume":"102","author":"AB West","year":"2005","unstructured":"West, A. B. et al. Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc. Natl Acad. Sci. USA 102, 16842\u201316847 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrn2935_CR28","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1038\/emboj.2008.163","volume":"27","author":"Y Imai","year":"2008","unstructured":"Imai, Y. et al. Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila. EMBO J. 27, 2432\u20132443 (2008).","journal-title":"EMBO J."},{"key":"BFnrn2935_CR29","doi-asserted-by":"publisher","first-page":"e00002","DOI":"10.1042\/AN20090007","volume":"1","author":"E Greggio","year":"2009","unstructured":"Greggio, E. & Cookson, M. R. Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions. ASN Neuro 1, e00002 (2009).","journal-title":"ASN Neuro"},{"key":"BFnrn2935_CR30","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1016\/j.bbapap.2010.05.004","volume":"1804","author":"B Lu","year":"2010","unstructured":"Lu, B. et al. Expression, purification and preliminary biochemical studies of the N-terminal domain of leucine-rich repeat kinase 2. Biochim. Biophys. Acta 1804, 1780\u20131784 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrn2935_CR31","doi-asserted-by":"publisher","first-page":"36346","DOI":"10.1074\/jbc.M109.025437","volume":"284","author":"S Sen","year":"2009","unstructured":"Sen, S., Webber, P. J. & West, A. B. Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization. J. Biol. Chem. 284, 36346\u201336356 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnrn2935_CR32","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1021\/bi901851y","volume":"49","author":"M Liu","year":"2010","unstructured":"Liu, M., Dobson, B., Glicksman, M. A., Yue, Z. & Stein, R. L. Kinetic mechanistic studies of wild-type leucine-rich repeat kinase 2: characterization of the kinase and GTPase activities. Biochemistry 49, 2008\u20132017 (2010).","journal-title":"Biochemistry"},{"key":"BFnrn2935_CR33","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/nn1776","volume":"9","author":"WW Smith","year":"2006","unstructured":"Smith, W. W. et al. Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nature Neurosci. 9, 1231\u20131233 (2006).","journal-title":"Nature Neurosci."},{"key":"BFnrn2935_CR34","first-page":"217","volume":"1","author":"MR Cookson","year":"2008","unstructured":"Cookson, M. R., Hardy, J. & Lewis, P. A. Genetic neuropathology of Parkinson's disease. Int. J. Clin. Exp. Pathol. 1, 217\u2013231 (2008).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"BFnrn2935_CR35","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/jnr.21622","volume":"86","author":"PN Gandhi","year":"2008","unstructured":"Gandhi, P. N., Wang, X., Zhu, X., Chen, S. G. & Wilson-Delfosse, A. L. The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules. J. Neurosci. Res. 86, 1711\u20131720 (2008).","journal-title":"J. Neurosci. Res."},{"key":"BFnrn2935_CR36","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1111\/j.1471-4159.2009.06235.x","volume":"110","author":"F Gillardon","year":"2009","unstructured":"Gillardon, F. Leucine-rich repeat kinase 2 phosphorylates brain tubulin-\u03b2 isoforms and modulates microtubule stability-a point of convergence in parkinsonian neurodegeneration? J. Neurochem. 110, 1514\u20131522 (2009).","journal-title":"J. Neurochem."},{"key":"BFnrn2935_CR37","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1093\/hmg\/ddp337","volume":"18","author":"RM Sancho","year":"2009","unstructured":"Sancho, R. M., Law, B. M. & Harvey, K. Mutations in the LRRK2 Roc-COR tandem domain link Parkinson's disease to Wnt signalling pathways. Hum. Mol. Genet. 18, 3955\u20133968 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrn2935_CR38","doi-asserted-by":"publisher","first-page":"e5949","DOI":"10.1371\/journal.pone.0005949","volume":"4","author":"X Ding","year":"2009","unstructured":"Ding, X. & Goldberg, M. S. Regulation of LRRK2 stability by the E3 ubiquitin ligase CHIP. PLoS ONE 4, e5949 (2009).","journal-title":"PLoS ONE"},{"key":"BFnrn2935_CR39","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1073\/pnas.0810123106","volume":"106","author":"HS Ko","year":"2009","unstructured":"Ko, H. S. et al. CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity. Proc. Natl Acad. Sci. USA 106, 2897\u20132902 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrn2935_CR40","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1111\/j.1471-4159.2010.06568.x","volume":"112","author":"CH Hsu","year":"2010","unstructured":"Hsu, C. H. et al. MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2. J. Neurochem. 112, 1593\u20131604 (2010).","journal-title":"J. Neurochem."},{"key":"BFnrn2935_CR41","doi-asserted-by":"publisher","first-page":"e8463","DOI":"10.1371\/journal.pone.0008463","volume":"4","author":"ND Jorgensen","year":"2009","unstructured":"Jorgensen, N. D. et al. The WD40 domain is required for LRRK2 neurotoxicity. PLoS ONE 4, e8463 (2009).","journal-title":"PLoS ONE"},{"key":"BFnrn2935_CR42","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.neuron.2006.10.008","volume":"52","author":"D MacLeod","year":"2006","unstructured":"MacLeod, D. et al. The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 52, 587\u2013593 (2006).","journal-title":"Neuron"},{"key":"BFnrn2935_CR43","doi-asserted-by":"publisher","first-page":"13971","DOI":"10.1523\/JNEUROSCI.3799-09.2009","volume":"29","author":"L Parisiadou","year":"2009","unstructured":"Parisiadou, L. et al. Phosphorylation of ezrin\/radixin\/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis. J. Neurosci. 29, 13971\u201313980 (2009).","journal-title":"J. Neurosci."},{"key":"BFnrn2935_CR44","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/j.1471-4159.2008.05217.x","volume":"105","author":"ED Plowey","year":"2008","unstructured":"Plowey, E. D., Cherra, S. J., Liu, Y. J. & Chu, C. T. Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY2015Y cells. J. Neurochem. 105, 1048\u20131056 (2008).","journal-title":"J. Neurochem."},{"key":"BFnrn2935_CR45","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.cub.2007.01.074","volume":"17","author":"A Sakaguchi-Nakashima","year":"2007","unstructured":"Sakaguchi-Nakashima, A., Meir, J. Y., Jin, Y., Matsumoto, K. & Hisamoto, N. LRK-1, a C. elegans PARK8-related kinase, regulates axonal-dendritic polarity of SV proteins. Curr. Biol. 17, 592\u2013598 (2007).","journal-title":"Curr. Biol."},{"key":"BFnrn2935_CR46","doi-asserted-by":"publisher","first-page":"16482","DOI":"10.1074\/jbc.M808255200","volume":"284","author":"J Samann","year":"2009","unstructured":"Samann, J. et al. Caenorhabditits elegans LRK-1 and PINK-1 act antagonistically in stress response and neurite outgrowth. J. Biol. Chem. 284, 16482\u201316491 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnrn2935_CR47","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/nn.2372","volume":"12","author":"LS Tain","year":"2009","unstructured":"Tain, L. S. et al. Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss. Nature Neurosci. 12, 1129\u20131135 (2009).","journal-title":"Nature Neurosci."},{"key":"BFnrn2935_CR48","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.cmet.2010.05.001","volume":"11","author":"P Kapahi","year":"2010","unstructured":"Kapahi, P. et al. With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging. Cell Metab. 11, 453\u2013465 (2010).","journal-title":"Cell Metab."},{"key":"BFnrn2935_CR49","doi-asserted-by":"publisher","first-page":"586","DOI":"10.18632\/aging.100070","volume":"1","author":"SL Hands","year":"2009","unstructured":"Hands, S. L., Proud, C. G. & Wyttenbach, A. mTOR's role in ageing: protein synthesis or autophagy? Aging 1, 586\u2013597 (2009).","journal-title":"Aging"},{"key":"BFnrn2935_CR50","doi-asserted-by":"publisher","first-page":"e8730","DOI":"10.1371\/journal.pone.0008730","volume":"5","author":"A Kumar","year":"2010","unstructured":"Kumar, A. et al. The Parkinson's disease associated LRRK2 exhibits weaker in vitro phosphorylation of 4E-BP compared to autophosphorylation. PLoS ONE 5, e8730 (2010).","journal-title":"PLoS ONE"},{"key":"BFnrn2935_CR51","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000289232","volume":"7","author":"C Wider","year":"2010","unstructured":"Wider, C., Dickson, D. W. & Wszolek, Z. K. Leucine-rich repeat kinase 2 gene-associated disease: redefining genotype-phenotype correlation. Neurodegener. Dis. 7, 175\u2013179 (2010).","journal-title":"Neurodegener. Dis."},{"key":"BFnrn2935_CR52","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/bies.200900163","volume":"32","author":"JM Taymans","year":"2010","unstructured":"Taymans, J. M. & Cookson, M. R. Mechanisms in dominant parkinsonism: the toxic triangle of LRRK2, \u03b1-synuclein, and tau. Bioessays 32, 227\u2013235 (2010).","journal-title":"Bioessays"},{"key":"BFnrn2935_CR53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1750-1326-4-9","volume":"4","author":"MR Cookson","year":"2009","unstructured":"Cookson, M. R. \u03b1-Synuclein and neuronal cell death. Mol. Neurodegener. 4, 9 (2009).","journal-title":"Mol. Neurodegener."},{"key":"BFnrn2935_CR54","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev.cellbio.042308.113313","volume":"26","author":"PK Auluck","year":"2010","unstructured":"Auluck, P. K., Caraveo, G. & Lindquist, S. \u03b1-Synuclein: membrane interactions and toxicity in Parkinson's disease. Annu. Rev. Cell Dev. Biol. 26, 211\u2013233 (2010).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"BFnrn2935_CR55","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/ana.21019","volume":"60","author":"S Biskup","year":"2006","unstructured":"Biskup, S. et al. Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann. Neurol. 60, 557\u2013569 (2006).","journal-title":"Ann. Neurol."},{"key":"BFnrn2935_CR56","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1212\/01.wnl.0000240220.33950.0c","volume":"67","author":"A Rajput","year":"2006","unstructured":"Rajput, A. et al. Parkinsonism, Lrrk2 G2019S, and tau neuropathology. Neurology 67, 1506\u20131508 (2006).","journal-title":"Neurology"},{"key":"BFnrn2935_CR57","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.tibs.2009.03.008","volume":"34","author":"D Matenia","year":"2009","unstructured":"Matenia, D. & Mandelkow, E. M. The tau of MARK: a polarized view of the cytoskeleton. Trends Biochem. Sci. 34, 332\u2013342 (2009).","journal-title":"Trends Biochem. Sci."},{"key":"BFnrn2935_CR58","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1195227","volume":"329","author":"J Burre","year":"2010","unstructured":"Burre, J. et al. \u03b1-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329, 1663\u20131667 (2010).","journal-title":"Science"},{"key":"BFnrn2935_CR59","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nrn2631","volume":"10","author":"C Conde","year":"2009","unstructured":"Conde, C. & Caceres, A. Microtubule assembly, organization and dynamics in axons and dendrites. Nature Rev. Neurosci. 10, 319\u2013332 (2009).","journal-title":"Nature Rev. Neurosci."},{"issue":"1-2","key":"BFnrn2935_CR60","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jneuroim.2010.07.021","volume":"229","author":"Makoto Kubo","year":"2010","unstructured":"Kubo, M. et al. LRRK2 is expressed in B-2 but not in B-1 B cells, and downregulated by cellular activation. J. Neuroimmunol. 20 Aug 2010 (doi:10.1016\/j.jneuroim.2010.07.021).","journal-title":"Journal of Neuroimmunology"},{"key":"BFnrn2935_CR61","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1042\/BJ20091035","volume":"424","author":"RJ Nichols","year":"2009","unstructured":"Nichols, R. J. et al. Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease. Biochem. J. 424, 47\u201360 (2009).","journal-title":"Biochem. J."},{"issue":"Suppl. 3","key":"BFnrn2935_CR62","doi-asserted-by":"publisher","first-page":"S205","DOI":"10.1016\/S1353-8020(09)70815-6","volume":"15","author":"K Haugarvoll","year":"2009","unstructured":"Haugarvoll, K. & Wszolek, Z. K. Clinical features of LRRK2 parkinsonism. Parkinsonism Relat. Disord. 15 (Suppl. 3), S205\u2013S208 (2009).","journal-title":"Parkinsonism Relat. Disord."},{"key":"BFnrn2935_CR63","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/ana.10113","volume":"51","author":"M Funayama","year":"2002","unstructured":"Funayama, M. et al. A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann. Neurol. 51, 296\u2013301 (2002).","journal-title":"Ann. Neurol."},{"key":"BFnrn2935_CR64","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/ana.20484","volume":"57","author":"M Funayama","year":"2005","unstructured":"Funayama, M. et al. An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family. Ann. Neurol. 57, 918\u2013921 (2005).","journal-title":"Ann. Neurol."},{"key":"BFnrn2935_CR65","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0140-6736(05)17829-5","volume":"365","author":"A Di Fonzo","year":"2005","unstructured":"Di Fonzo, A. et al. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 365, 412\u2013415 (2005).","journal-title":"Lancet"},{"key":"BFnrn2935_CR66","first-page":"415","volume":"365","author":"WP Gilks","year":"2005","unstructured":"Gilks, W. P. et al. A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 365, 415\u2013416 (2005).","journal-title":"Lancet"},{"key":"BFnrn2935_CR67","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1086\/429256","volume":"76","author":"J Kachergus","year":"2005","unstructured":"Kachergus, J. et al. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am. J. Hum. Genet. 76, 672\u2013680 (2005).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrn2935_CR68","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1056\/NEJMc055540","volume":"354","author":"S Lesage","year":"2006","unstructured":"Lesage, S. et al. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N. Engl. J. Med. 354, 2422\u20132423 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnrn2935_CR69","first-page":"410","volume":"365","author":"WC Nichols","year":"2005","unstructured":"Nichols, W. C. et al. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 365, 410\u2013412 (2005).","journal-title":"Lancet"},{"key":"BFnrn2935_CR70","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1056\/NEJMc055509","volume":"354","author":"LJ Ozelius","year":"2006","unstructured":"Ozelius, L. J. et al. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N. Engl. J. Med. 354, 2424\u20132425 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnrn2935_CR71","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1001\/archneur.63.9.1250","volume":"63","author":"L Ishihara","year":"2006","unstructured":"Ishihara, L. et al. Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations. Arch. Neurol. 63, 1250\u20131254 (2006).","journal-title":"Arch. Neurol."},{"key":"BFnrn2935_CR72","doi-asserted-by":"publisher","first-page":"6455","DOI":"10.1111\/j.1742-4658.2009.07344.x","volume":"276","author":"U Kumari","year":"2009","unstructured":"Kumari, U. & Tan, E. K. LRRK2 in Parkinson's disease: genetic and clinical studies from patients. FEBS J. 276, 6455\u20136463 (2009).","journal-title":"FEBS J."},{"key":"BFnrn2935_CR73","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1749-6632.2009.05118.x","volume":"1184","author":"GM Halliday","year":"2010","unstructured":"Halliday, G. M. & McCann, H. The progression of pathology in Parkinson's disease. Ann. NY Acad. Sci. 1184, 188\u2013195 (2010).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrn2935_CR74","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"}],"container-title":["Nature Reviews Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrn2935.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrn2935","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrn2935.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:16:18Z","timestamp":1684469778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrn2935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,19]]},"references-count":74,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["BFnrn2935"],"URL":"https:\/\/doi.org\/10.1038\/nrn2935","relation":{},"ISSN":["1471-003X","1471-0048"],"issn-type":[{"value":"1471-003X","type":"print"},{"value":"1471-0048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,19]]}}}